Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Caroline S Fox, Sherita Hill Golden, Cheryl Anderson, George A Bray, Lora E Burke, Ian H de Boer, Prakash Deedwania, Robert H Eckel, Abby G Ershow, Judith Fradkin, Silvio E Inzucchi, Mikhail Kosiborod, Robert G Nelson, Mahesh J Patel, Michael Pignone, Laurie Quinn, Philip R Schauer, Elizabeth Selvin, Dorothea K Vafiadis, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association, Caroline S Fox, Sherita Hill Golden, Cheryl Anderson, George A Bray, Lora E Burke, Ian H de Boer, Prakash Deedwania, Robert H Eckel, Abby G Ershow, Judith Fradkin, Silvio E Inzucchi, Mikhail Kosiborod, Robert G Nelson, Mahesh J Patel, Michael Pignone, Laurie Quinn, Philip R Schauer, Elizabeth Selvin, Dorothea K Vafiadis, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association
Abstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
Keywords: AHA Scientific Statements; cardiovascular disease; diabetes; primary prevention.
Conflict of interest statement
The American Heart Association and the American Diabetes Association make every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
© 2015 American Heart Association, Inc.
Source: PubMed